StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.05−0.12 (-5.53%)

Close on Nov 17, 2026Market cap $130.59MP/E –Yield –

MacroGenics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MacroGenics's price to book ratio was 3.4× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.7× to 13.9×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.4×+1.9
2025Dec 31, 20251.5×−0.2
2024Dec 31, 20241.7×−1.4
2023Dec 29, 20233.1×−0.3
2022Dec 30, 20223.4×−0.0
2021Dec 31, 20213.4×−1.0
2020Dec 31, 20204.4×+2.3
2019Dec 31, 20192.1×+0.2
2018Dec 31, 20181.9×−1.8
2017Dec 29, 20173.7×+1.3
2016Dec 30, 20162.4×−0.8
2015Dec 31, 20153.1×−3.9
2014Dec 31, 20147.0×–

More MacroGenics figures

See a number that looks wrong?